Curcumin vs. Placebo

A Phase 2, Double-blind, Randomized Study to Compare the Effect of Curcumin Versus Placebo on Inflammatory Cytokines, Symptoms and Disease Parameters in Clonal Cytopenia of Undetermined Significance (CCUS), Low-Risk Myelodysplastic Syndrome (LR-MDS), and Myeloproliferative Neoplasms (MPNs)

More Information

Trial Status
Accepting patients
Trial Phase
Phase 2
Enrollment
30 patients (estimated)
Sponsors
University of Southern California
Collaborators
National Cancer Institute (NCI)
Tags
Placebo, Randomization
Trial Type
Treatment
Last Update
2 months ago
SparkCures ID
1779
NCT Identifier
NCT06063486

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.